Citadel Advisors »

Lyell Immunopharma shares owned by Citadel Advisors

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.8M 792k 2.23
2023-12-31 $6.8M 3.5M 1.94
2023-09-30 $1.1M 760k 1.47
2023-06-30 $141k 44k 3.18
2023-03-31 $150k 63k 2.36
2022-12-31 $76k 22k 3.47
2022-03-31 $1.3M 261k 5.05
2021-12-31 $2.8M 358k 7.74
2021-09-30 $2.7M 188k 14.64
2021-06-30 $5.3M 328k 16.23